{
  "docId": "019de071-a0aa-74fc-b780-f72cc7f02158",
  "docSlug": "6af314fff9e6eaaf966098f4c73a6229",
  "documentTitle": "Mink Therapeutics | IPO Presentation Deck | 36 slides",
  "authorId": "mink-therapeutics",
  "authorName": "MiNK Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7860465,
  "pageNumber": 20,
  "pageCount": 36,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "context",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a Kaplan-Meier survival curve to demonstrate the efficacy of iNKT cells in a mouse model.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-a0aa-74fc-b780-f72cc7f02158/20",
  "deckHref": "/decks/019de071-a0aa-74fc-b780-f72cc7f02158",
  "deckJsonHref": "/decks/019de071-a0aa-74fc-b780-f72cc7f02158.json",
  "deckAnchorHref": "/decks/019de071-a0aa-74fc-b780-f72cc7f02158#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.35,
        "x": 0.578,
        "y": 0.288
      },
      "kind": "chart",
      "text": "Activated iNKTs Prolong Survival in Severe Influenza",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77d2a459-5c27-4701-93f8-769b5bfe015d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.08,
        "x": 0.438,
        "y": 0.445
      },
      "kind": "image",
      "text": "iNKTs",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "17bf55dd-a5e4-47e4-918c-23320a82321e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.41,
        "x": 0.04,
        "y": 0.28
      },
      "kind": "paragraph",
      "text": "Acute respiratory distress syndrome (ARDS) is inflammation driven respiratory failure in viral infections. Approximately 40% of patients with ARDS die of lung failure. iNKTs may dampen inflammatory cytokines (IL-1 & IL-6), protect epithelial cells from damage (IL-22), clear virus, and may prevent reinfection. Ongoing Ph1 trial in ARDS (in COVID-19) demonstrates safety up to 1Bn cells/dose; Phase 2 expansion of ARDS (COVID and influenza) underway",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4026b93-1a04-4003-9520-6eec4248bf6b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.06,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "Global Data GvHD Report 2020; Kok et al, J Leukocyte Biol, 2012",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "66ffdec3-578f-4e4e-a82a-b8db716c42d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.58,
        "x": 0.21,
        "y": 0.12
      },
      "kind": "title",
      "text": "Versatile cells for suppressing inflammatory cytokines and fighting infection",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "079d79b5-41f3-46c5-bfca-19c737a848ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.76,
        "x": 0.12,
        "y": 0.04
      },
      "kind": "title",
      "text": "iNKT Development in ARDS and Viral Infections",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "803d5c72-741e-4070-af61-75983d4c6e5b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "evidence-matrix",
      "slug": null,
      "matchId": "afdab6f4-a820-4015-a794-ad904d9c7845",
      "evidence": "Combines clinical trial status with preclinical survival data to support therapeutic thesis.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 36,
      "from": 5,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "ff1f25c5-6e00-4a50-9457-841955937c0b",
      "evidence": "The document presents the why, what, and how of MiNK's iNKT cell therapies throughout the deck.",
      "position": 0,
      "objective": "Why MiNK Therapeutics' iNKT cell therapies are needed and how they work",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    },
    {
      "to": 34,
      "from": 14,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "1930f29c-63d8-4add-8285-7c1514ed675c",
      "evidence": "The document outlines multiple near-term milestones and clinical readouts.",
      "position": 1,
      "objective": "Highlighting near-term milestones and clinical readouts as a quick win and a big bet on iNKT cell therapies",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}